Continued penetration into global markets, with nearly 36% of Q3 revenue generated internationally, compared to 20% in Q2 2025. Product Innovation: Ongoing investment in R&D to expand applications of ...

In early November 2025, CONMED Corporation announced a new share repurchase program of up to US$150 million, suspended its quarterly cash dividend, and raised its full-year revenue guidance following ...